Nectar Lifescience Ltd Share Price
(NECLIFE)
₹23.41▲2.86%
as on 11:17AM, 24 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -6.26 % |
3 Month Return | -40.91 % |
1 Year Return | -34.22 % |
Market Stats | |
Previous Close | ₹22.76 |
Open | ₹22.75 |
Volume | 5.18L |
Upper Circuit | ₹25.03 |
Lower Circuit | ₹20.48 |
Market Cap | ₹510.42Cr |
P/E Ratio
29.95
PEG Ratio
74.87
Market Cap
₹510.42 Cr
P/B Ratio
0.63
EPS
0.22
Dividend Yield
0Sector
Pharmaceuticals
ROE
0.47
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 359.85 Cr → 455.56 Cr (in ₹), with an average increase of 11.0% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 0.73% to 1.65% in Mar 2025 quarter
Profit Spike
Netprofit is up for the last 4 quarters, 0.59 Cr → 7.84 Cr (in ₹), with an average increase of 51.9% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 56.9% return, outperforming this stock by 88.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.53% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.6% return, outperforming this stock by 159.5%
Retail Holding Down
Retail Investor have decreased holdings from 54.72% to 53.65% in Mar 2025 quarter
Price Dip
In the last 3 months, NECLIFE stock has moved down by -41.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.53% | 0.00 | |
Foreign Institutions | 1.65% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 53.65% | 0.00 | |
Others | 0.18% | 0.00 |
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Today (29.95x)
April 23, 2025
Industry (53.87x)
April 23, 2025
Highest (403.33x)
August 26, 2020
Nectar Lifescience Ltd’s net profit jumped 399.36% since last year same period to ₹7.84Cr in the Q3 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 40% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.22%.
Read More about DividendsBearish
Neutral
Bullish
Nectar Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹510.42 Cr | 10.35% | 0.69 | ₹5 Cr | ₹1,684 Cr | |
NA | ₹11.15 Cr | 66.72% | 0.50 | NA | NA | |
NA | ₹2,987.44 Cr | 39.26% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
NA | ₹520.52 Cr | 260.56% | 0.73 | ₹7 Cr | ₹1 Cr | |
NA | ₹157.93 Cr | 105.19% | 0.69 | NA | NA |
Organisation | Nectar Lifescience Ltd |
Headquarters | Chandigarh |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Nectar Lifescience Ltd share price today stands at ₹23.41, Open: ₹22.75, Previous Close: ₹22.76, High: ₹23.68, Low: ₹22.75, 52 Week High: ₹56.5, 52 Week Low: ₹20.99.
Today's traded volume of Nectar Lifescience Ltd(NECLIFE) is 5.18L.
Today's market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹510.42Cr.
Nectar Lifescience Ltd (NECLIFE) share price is ₹23.41. It is down -58.57% from its 52 Week High price of ₹56.5
Nectar Lifescience Ltd (NECLIFE) share price is ₹23.41. It is up 11.53% from its 52 Week Low price of ₹20.99